Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mara Hofstetter
Observed names:
Hofstetter, Mara Carina,
Mara C. Hofstetter
Institutions:
University of Zurich,
University Hospital Zurich
Observed institutions:
University of Zurich,
Yale University,
ETH Zurich,
University Hospital Zurich,
Institute of Pharmaceutical Sciences
ORCID:
0000-0002-5058-576X
Observed ORCID:
0000-0002-5058-576X
OpenAlex ID:
A5138299693
Calreticulin mutations affect its chaperone function and perturb the glycoproteome
2022
·
Patrick M. Schürch
, Liliana Malinovska
, et al.
·
Cell Reports
·
37
PDF
Efficient combinatorial adaptor-mediated targeting of acute myeloid leukemia with CAR T-cells
2024
·
Laura Volta
, Renier Myburgh
, et al.
·
Leukemia
·
25
PDF
A single‐chain variable fragment‐based bispecific T‐cell activating antibody against CD117 enables T‐cell mediated lysis of acute myeloid leukemia and hematopoietic stem and progenitor cells
2024
·
Laura Volta
, Renier Myburgh
, et al.
·
HemaSphere
·
13
PDF
Chitinase 3-like-1 (CHI3L1) in the pathogenesis of epidermal growth factor receptor mutant non-small cell lung cancer
2024
·
Suchitra Kamle
, Bing Ma
, et al.
·
Translational Oncology
·
8
Proteomic identification of proliferation and progression markers in human polycythemia vera stem and progenitor cells
2022
·
Ge Tan
, Witold E. Wolski
, et al.
·
Blood Advances
·
7
PDF
A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells
2026
·
Laura G. Volta
, Celeste Gobbi
, et al.
·
Molecular Cancer Therapeutics
·
1
PDF
Efficient Combinatorial Adaptor-Mediated Targeting of Acute Myeloid Leukemia with CAR T-Cells
2023
·
Laura Volta
, Renier Myburgh
, et al.
·
Blood
·
1
PDF
Supplementary Table S2 from A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells
2026
·
Laura G. Volta
, Celeste Gobbi
, et al.
Supplementary Table S1 from A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells
2026
·
Laura G. Volta
, Celeste Gobbi
, et al.
Supplementary Figure S4 from A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells
2026
·
Laura G. Volta
, Celeste Gobbi
, et al.
Supplementary Figure S1 from A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells
2026
·
Laura G. Volta
, Celeste Gobbi
, et al.
Supplementary Figure S5 from A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells
2026
·
Laura G. Volta
, Celeste Gobbi
, et al.
Data from A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells
2026
·
Laura G. Volta
, Celeste Gobbi
, et al.
Supplementary Figure S2 from A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells
2026
·
Laura G. Volta
, Celeste Gobbi
, et al.
Supplementary Figure S3 from A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells
2026
·
Laura G. Volta
, Celeste Gobbi
, et al.
Supplementary Figure S5 from Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
Figure 4 from Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
Supplementary Figure S3 from Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
Figure 5 from Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
Supplementary Figure S2 from Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
Figure 2 from Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
Supplementary Table S1 from Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
Supplementary Figure S6 from Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
Supplementary Figure S4 from Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
Figure 3 from Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia
2026
·
Mara Hofstetter
, Laura Volta
, et al.
Show more works
View as search
Works count:
33
Citation count:
92
H-index:
5
I10-index:
3
Year
Topic
Type